2025 - Director Statement PT MPI.pdf

MP

PT MILLENNIUM PHARMACON INTERNATIONAL Tbk

SURAT PERNYATAAN DIREKSI
TENTANG TANGGUNG JAWAB ATAS
LAPORAN KEUANGAN KONSOLIDASIAN
31 DESEMBER 2025
PT MILLENNIUM PHARMACON INTERNATIONAL Tbk
DAN ENTITAS ANAK

DIRECTORS' STATEMENT
REGARDING THE RESPONSIBILITY FOR
THE CONSOLIDATED FINANCIAL STATEMENTS
31 DECEMBER 2025
PT MILLENNIUM PHARMACON INTERNATIONAL Tbk
AND ITS SUBSIDIARY

Kami, yang bertanda tangan di bawah ini: We, the undersigned:

Nama
Alamat kantor

Dr.Imam Fathorrahman MM.
Crown Bungur Arteri Lt, 2-4
Jl. Sultan Iskandar Muda No. 18
Kel. Kebayoran Lama Selatan,
Kec, Kebayoran Lama - Jakarta Selatan
Jl Tebet Utara IV B No.3 RT 003/002 :
Kel. Tebet Timur, Kec. Tebet -
Jakarta Selatan
(62-21) 27085961

Name
Office address

Alamat domisili Residential Address

Nomor telepon Phone Number

Jabatan Direktur Utama/ President Director Position
Nama Mohamad Fazly bin Hassan Name
Alamat kantor Crown Bungur Arteri Lt, 2-4 Office address
JL Sultan Iskandar Muda No. 18
Kel. Kebayoran Lama Selatan,
Kec. Kebayoran Lama - Jakarta Selatan
Alamat domisili Jl. Apartement Hamptons Park Residential Address
Tower A Unit 8 F,
Jl Terogong Raya No. 18 Cilandak Barat
Nomor telepon (62-21) 27085961 Phone Number
Jabatan Direktur/ Director Position
menyatakan bahwa: declare that:
1. Kami bertanggung jawab atas penyusunan dan 1. We are responsible for the preparation and

penyajian laporan keuangan — konsolidasian
PT Millennium Pharmacon International Tbk dan
entitas anak,

presentation of the consolidated financial statements
Of PT Millennium Pharmacon International Tbk and its
subsidiary,

The consolidated financial — statements of
PT Millennium Pharmacon International Tbk and its

2. Laporan keuangan konsolidasian PT Millennium 2.
Pharmacon International Tbk dan entitas anak telah

disusun dan disajikan sesuai dengan Standar subsidiary have been prepared and presented in
Akuntansi Keuangan di Indonesia, accordance with the Financial Accounting Standards

in Indonesia,
3. a. Semua informasi dalam laporan keuangan 3. a. All information in the consolidated financial

konsolidasian PT Millennium — Pharmacon statements of. PT Millennium — Pharmacon

International Tbk dan entitas anak telah dimuat
secara lengkap dan benarj

b. Laporan keuangan konsolidasian PT Millennium
Pharmacon International Tbk dan entitas anak
tidak mengandung informasi atau fakta material
yang tidak benar, dan tidak menghilangkan
informasi atau fakta material, .

Bertanggung jawab atas sistem pengendalian intern
dalam PT Millennium Pharmacon International Tbk
dan entitas anak.

Demikian pernyataan ini dibuat dengan sebenarnya.

International Tbk and its subsidiary have been
disclosed in a complete and truthful mannerj

The consolidated financial statements of
PT Millennium Pharmacon International Tbk and
its subsidiary do not contain misleading material
information or facts, and do not conceal any
material information or facts:

4. We are responsible for PT Millennium Pharmacon
International Tbk and its subsidiary's internal control
system.

This statement letter is made truthfully.

Jakarta, 30 Maret/March 2026

Dr.Imam Fathorrahman MM."
Direktur Utama/ President Director

“) menjabat sejak 14 Januari 2026

7ANX352011

FI
TEMP

“3

1
METERAT

Mohamad Fazly bin Hassan
Direktur/Director

“) serve since 14 January 2026

Crown Bungur Arteri 2-4th Floors

Jl. Sultan Iskandar Muda No. 18, Jakarta 12240, Indonesia

Phone : #6221 27085961